GTCM
PAHC icon

Gyon Technologies Capital Management’s Phibro Animal Health PAHC Stock Holding History

Gyon Technologies Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,090
Closed -$320K – 577
2022
Q3 		$320K Buy
24,090
+11,302
+88% +$195K 0.1% 260
2022
Q2 		$245K Buy
+12,788
New +$242K 0.07% 340

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SGCIA
Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return

Gyon Technologies Capital Management's PAHC Position: Q4 2022 in Review

Gyon Technologies Capital Management sold out of Phibro Animal Health (PAHC) in Q4 2022, closing a stake of 24,090 shares — an estimated $320K sold.

Gyon Technologies Capital Management first reported a position in PAHC in Q2 2022 and held it in 2 quarters. The position peaked at $320K in Q3 2022. 132 funds tracked by Wall St. Rank hold PAHC as of Q4 2022.

  • Gyon Technologies Capital Management reported no remaining Phibro Animal Health position as of Q4 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 24,090 Phibro Animal Health shares in Q4 2022, an estimated $320K.
  • Gyon Technologies Capital Management first reported a position in Phibro Animal Health in Q2 2022 and held it in 2 quarters.
  • Gyon Technologies Capital Management's Phibro Animal Health position peaked at $320K in Q3 2022.
  • 132 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.